Bringing this thread back up since I'm curious too, especially about the oral version which is said to absorb better than plain BPC.
Has anyone here actually tried PDA themselves?
Pentadeca-Arginate PDA vs BPC-157
Summary
What this discussion establishesHow does PDA compare to BPC-157 in effects, stability, and bioavailability, especially in oral form?
- PDA described as BPC with one extra arginine attached
- No noticeable difference reported between PDA and BPC when used injectably
- Claims of improved stability and oral bioavailability for PDA
- Viewed as a regulatory workaround after BPC status changes
Whether PDA truly offers superior results or is mainly a workaround, and why it lacks widespread adoption or sources
Nothing here is advice.
7 replies · 4 people
↳ replying to @KeenPebble65
Looks like just the two of us are wondering about this!
I gave the compounded version a shot and noticed nothing different from BPC. The explanation I got was that it's basically the same as BPC except for one added arginine so it counts as a separate compound.
↳ replying to @LevelFenwick18
From what I saw it was meant to improve stability.
Found an interview with a practitioner who mentioned switching his work from BPC over to PDA. Seems like a response to the recent regulatory shift on BPC. He also noted better oral uptake with PDA compared to BPC.
Reviving the discussion again. PDA came up for me recently and I looked into it, quickly seeing the link to BPC-157. A sports research site claimed it has better stability and bioavailability. Given how popular BPC is, why does PDA never show up on peptide lists or gain traction? Anyone know a source? Also, does this mean we're relying on anecdotal use for the injectable since oral effects seem more discussed?
Related discussions
Add your experience
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.